Serena Lorini

SC22 HBV and HCV testing in Italy’s marginalized groups: advancing who’s 2030 elimination goal

Teresita Caruso, I. Giorgi, Mario Monti, Alice Castellaccio et autres

HBV and HCV testing outcomes among marginalized communities in Italy, 2019–2024: a prospective study

Monica Monti, Teresita Caruso, Alice Castellaccio, Irene Giorgi et autres

it (code pays fourni par la source)

Outcomes of HBV and HCV Testing in Italy's Marginal Communities: A Step Towards Who Hepatitis Elimination

Monica Monti, Teresita Caruso, Alice Castellaccio, Irene Giorgi et autres

it, us, cz (code pays fourni par la source)

Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase

Clodoveo Ferri, Vincenzo Raimondo, Dilia Giuggioli, Laura Gragnani et autres

it, cl (code pays fourni par la source)

Evaluation of Plasma miR-17-5p, miR-24-3p and miRNA-223-3p Profile of Hepatitis C Virus-Infected Patients after Treatment with Direct-Acting Antivirals

Zehra Öksüz, Laura Gragnani, Serena Lorini, Gülhan Örekici Temel et autres

tr, it (code pays fourni par la source)

Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate

Cecilia Napodano, Gabriele Ciasca, Patrizia Chiusolo, Krizia Pocino et autres

it (code pays fourni par la source)

COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity

Laura Gragnani, Marcella Visentini, Serena Lorini, Stefano Angelo Santini et autres

it (code pays fourni par la source)

Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases

Clodoveo Ferri, Laura Gragnani, Vincenzo Raimondo, Marcella Visentini et autres

it, cz (code pays fourni par la source)

Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies

Clodoveo Ferri, Vincenzo Raimondo, Laura Gragnani, Dilia Giuggioli et autres

it (code pays fourni par la source)

B‐cell activating factor (BAFF), BAFF promoter and BAFF receptor allelic variants in hepatitis C virus related Cryoglobulinemic Vasculitis and Non‐Hodgkin's Lymphoma

Laura Gragnani, Serena Lorini, Silvia Marri, Sara Rattotti et autres

it (code pays fourni par la source)

COVID-19 vaccine immunogenicity in 16 patients with autoimmune systemic diseases. Lack of both humoral and cellular response to booster dose and ongoing disease modifying therapies

Laura Gragnani, Marcella Visentini, Serena Lorini, Francesca La Gualana et autres

it (code pays fourni par la source)

Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2

Marcella Visentini, Laura Gragnani, Stefano Angelo Santini, Teresa Urraro et autres

it (code pays fourni par la source)